David Malek, M.B.A.

David Malek, M.B.A., serves as a member of Braveheart Bio’s board of directors and previously served as President of the board of directors from May 2024 to October 2025. Currently, Mr. Malek is the Co-Founder and Chief Operating Officer of an early development life sciences company. Previously, he held various roles at Pivotal Life Sciences LLC, a life sciences venture capital firm investing in transformative therapeutic-focused healthcare companies, including as Operating Partner, Investment Director and Venture Partner. Mr. Malek has served as the Chief Business Officer at OncXerna Therapeutics, Inc., Arctic Vision Ltd., and BioLineRx Ltd. (Nasdaq: BLRX). He holds a B.A. from the University of Haifa and an M.B.A. from the Tuck School of Business at Dartmouth College.